Fill in the form below and our experts will get back to you within 1 business day.
Accelerate strain characterization and phenotype validation with our advanced high-throughput screening platforms. From FACS-based sorting to droplet microfluidics and multi-parameter plate assays, we deliver comprehensive testing solutions that power your Design-Build-Test-Learn cycles.
Trusted by leading research and pharmaceutical institutions
Up to 10⁷ cells/second throughput
Picoliter-scale screening at 10⁸ droplets/second
Automated 384/1536-well format
Our Test services provide comprehensive high-throughput screening capabilities that enable rapid phenotyping and characterization of engineered biological systems. From single-cell sorting to population-level analysis, we deliver the data you need to close the Design-Build-Test-Learn cycle efficiently.
FACS enables high-throughput screening of millions of cells based on fluorescent markers. Ideal for strain selection, pathway optimization, and protein engineering applications.
Droplet-based screening platforms enable ultra-high-throughput screening of enzyme variants, secreted products, and cell-free systems at picoliter scale.
High-density plate screening with automated liquid handling for detailed kinetic measurements and multi-parameter characterization of biological variants.
Partner with us to access cutting-edge screening technologies and expertise
Our screening infrastructure combines multiple detection modalities with advanced automation to deliver comprehensive phenotyping data across diverse biological systems.
Advanced flow cytometry platforms enabling multi-parameter analysis and high-speed cell sorting for diverse applications including strain selection and protein engineering.
Droplet-based screening systems for ultra-high-throughput enzyme evolution, metabolic screening, and cell-free expression optimization.
Automated high-density plate handling with integrated detection systems for kinetic measurements, growth profiling, and metabolite quantification.
Custom biosensor engineering including genetically encoded fluorescent reporters, FRET-based sensors, and cell-free transcription-translation systems.
| Technology | Throughput | Readout |
|---|---|---|
| FACS | 10⁷ cells/sec | Fluorescence |
| Droplet Microfluidics | 10⁸ droplets/sec | Various |
| Plate Screening | 10³-10⁴ wells | Multi-parameter |
| Flow Cytometry | 10⁴ cells/sec | Multi-color |
Technology selection depends on your specific screening goals and biological system. Our team can help design the optimal screening strategy.
Comprehensive testing capabilities with flexible configuration options to meet your specific research requirements.
Our team can develop custom screening protocols and assays tailored to your specific biological system and research objectives. Contact us to discuss your unique requirements.
A streamlined process designed to deliver high-quality screening data efficiently and reproducibly.
Initial discussion to understand your screening goals, biological system, and data requirements. We review your strain libraries and define appropriate controls.
Custom assay development and optimization, including biosensor engineering, detection method validation, and pilot testing with representative samples.
Large-scale screening execution with rigorous quality control, including positive/negative controls on each plate, replicate validation, and real-time monitoring.
Comprehensive data analysis including statistical processing, hit ranking, clustering analysis, and integration with downstream characterization workflows.
Our high-throughput screening platforms support diverse applications across metabolic engineering, protein engineering, and synthetic biology research.
High-throughput screening of strain libraries for improved production of fuels, chemicals, and pharmaceuticals. FACS-based sorting of strains carrying biosensor outputs.
Ultra-high-throughput screening of enzyme variant libraries using droplet microfluidics. Identification of improved catalysts for industrial and therapeutic applications.
Multi-parameter flow cytometry analysis of genetic circuit performance across large variant libraries. Quantitative characterization of promoter and RBS strengths.
FRET-based and split-reporter screening for identification and optimization of protein-protein interactions. Membrane protein and antibody engineering support.
Cell-based screening for identification of therapeutic leads, mechanism of action studies, and cytotoxicity profiling. Support forCAR-T and immune cell engineering.
Engineering and characterization of genetically encoded biosensors for metabolite detection, stress response monitoring, and pathway performance readout.
Hear from researchers who have accelerated their DBTL cycles with our screening services.
"The droplet microfluidics screening service enabled us to screen over 10 million enzyme variants in a single day. This accelerated our directed evolution project significantly."
Research Lead
Metabolic Engineering Lab
"Their FACS capabilities and custom biosensor development helped us identify high-producing strains with unprecedented precision. The data quality exceeded our expectations."
Principal Investigator
Industrial Biotechnology
"Working with their team on assay development was seamless. They understood our biological system and delivered a screening protocol that provided actionable data immediately."
Senior Scientist
Synthetic Biology Startup
Find answers to common questions about our high-throughput screening services.
Get a customized quote for your Test project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.